← SynDRA

VIMSELTINIB

SynDRA canonical compound SYN0040450 — structure-anchored drug synonym record

All known targets

• CSF1R
• KIT
• PDGFRA

Mechanisms of action (all sources)

• CSF1R INHIBITOR
• KIT INHIBITOR
• PDGFRA INHIBITOR

Cross-references

• PubChem CID: 86267612
• ChEMBL: CHEMBL5095202
• DrugBank: DB17520
• KEGG: D12238
• RxNorm: 2705378
• PDB: Z6V
• Wikipedia: Vimseltinib
• TTD: D9RH0V

Synonyms

• DCC-3014
• DP-6865
• UNII-PX9FTM69BF
• PX9FTM69BF
• DCC3014
• 2-(isopropylamino)-3-methyl-5-(6-methyl-5-((2-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yl)oxy)pyridin-2-yl)pyrimidin-4(3H)-one
• 3-methyl-5-[6-methyl-5-[2-(1-methylpyrazol-4-yl)pyridin-4-yl]oxypyridin-2-yl]-2-(propan-2-ylamino)pyrimidin-4-one
• Vimseltinib [INN]
• SCHEMBL16047448
• GTPL11190
• EX-A4700
• NSC828316
• NSC-828316
• example 10 [WO2014145025A2]
• HY-136256
• CS-0121044
• 3-Methyl-2-((1-methylethyl)amino)-5-(6-methyl-5-((2-(1-methyl-1H-pyrazol-4-yl)-4-pyridinyl)oxy)-2-pyridinyl)-4(3H)-pyrimidinone
• 4(3H)-Pyrimidinone, 3-methyl-2-((1-methylethyl)amino)-5-(6-methyl-5-((2-(1-methyl-1H-pyrazol-4-yl)-4-pyridinyl)oxy)-2-pyridinyl)-
• DCC 3014
• Vimseltinib [USAN]
• VIMSELTINIB [WHO-DD]
• compound 20 [PMID: 35961460]
• compound 20 (PMID: 35961460)
• example 10 (WO2014145025A2)
• RefChem:194257
• CSF1R Inhibitor DCC-3014
• ROMVIMZA
• MFCD32858282
• Vimseltinib (USAN/INN)
• Vimseltinib [USAN:INN]
• DCC-3014(Vimseltinib)?
• orb1309886
• SCHEMBL30453793
• YQF2536
• TVGAHWWPABTBCX-UHFFFAOYSA-N
• BDBM50589669
• WHO 11443
• AKOS040732693
• EBC-415078